Výsledky vyhledávání - "J. K. Choksi"

A phase II, multicenter evaluation of docetaxel, gemcitabine, and bevacizumab followed by bevacizumab alone in patients with locally advanced or metastatic non-small cell lung cancer (central localization excluded)

Autor: K. Kojouri, D. Bradford, S. Kobina, Mark A. Socinski, Rafat Ansari, J. K. Choksi, Kendrith M. Rowland, G. Gross

Publikováno v: Journal of Clinical Oncology. 26:19077-19077

19077 Background: Platinum-based doublets are the standard of care for advanced and metastatic NSCLC; however many patients (pts) can not tolerate side effects of this combination. This study was d...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c0d03b072813697f88eda5bd5daa99d
https://doi.org/10.1200/jco.2008.26.15_suppl.19077

Zobrazit plný text záznamu

A phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on lean body mass (LBM), weight (wt) and quality of life (QOL) in patients with solid tumors and weight loss receiving chemotherapy

Autor: Richard P. McQuellon, Edward G. Shaw, F. Ottery, George Sanders, Robin Rosdhal, Douglas Case, J. K. Choksi, Glenn J. Lesser

Publikováno v: Journal of Clinical Oncology. 26:9513-9513

9513 Background: Involuntary wt loss is a significant problem in patients (pts) with cancer which disproportionately represents a loss of muscle mass. Ox is a potent oral anabolic steroid exhibiting minimal androgenic effects which promotes wt gain p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fab7b02c79b93e226aff51e7b333fc91
https://doi.org/10.1200/jco.2008.26.15_suppl.9513

Zobrazit plný text záznamu

A Phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on weight (wt), lean body mass (LBM) and quality of life (QOL) in solid tumor patients (pts) receiving chemotherapy (chemo)

Autor: Glenn J. Lesser, Antonius A. Miller, Douglas Case, J. K. Choksi, S. Sharp, James N. Atkins, Edward G. Shaw

Publikováno v: Journal of Clinical Oncology. 24:18546-18546

18546 Background: Involuntary wt loss is a significant problem in pts with cancer and may lead to a decline in QOL, limit treatment options and reduce survival. Wt loss in these pts disproportionately represents a loss of muscle mass. Meg, a syntheti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a423dc3500506c56f8efc193b7eef1e6
https://doi.org/10.1200/jco.2006.24.18_suppl.18546

Zobrazit plný text záznamu

A phase III study of induction therapy with gemcitabine + carboplatin (GC) followed by either delayed vs. immediate second-line therapy with docetaxel (D) in advanced non-small cell lung cancer (NSCLC)

Autor: J. H. Schiller, P. Fidias, S. R. Dakhil, A. P. Lyss, J. A. Figueroa, J. K. Choksi, D. M. Loesch, L. P. Bloss, Z. Ye, C. K. Obasaju

Publikováno v: Journal of Clinical Oncology. 23:7142-7142

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::460c0a576beeee9be0a61aa12aacc5ed
https://doi.org/10.1200/jco.2005.23.16_suppl.7142

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání